Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Bone mass and bone modelling markers in hypertensive postmenopausal women

Abstract

Numerous phosphocalcium alterations associated with bone mineral density in hypertension have been described, but very few studies assess them. This study assesses bone mass in hypertensive postmenopausal women and the hypertension influence determining both calcium homeostasis and bone turnover markers. Blood and urine samples were analysed for calcium metabolism-related parameters. Densitometry studies were conducted in the lumbar spine (L2–L4). Hypertensive osteoporotic women—selected from 82 women, with 22% osteoporosis prevalence, similar to the rate for the same age in the Spanish population—had significantly higher levels of body mass index (29±4 vs 26±4, P=0.019), calciuria (293±146 vs 210±116 mg/24 h, P=0.023) and calcium/creatinine ratio (0.33±0.2 vs 0.22±0.1 P=0.003) vs hypertensive nonosteoporotic women. No relation was found between systolic and diastolic blood pressure with bone mass. However, there was a negative osteocalcin correlation (r=−0.386, P=0.0001, and r=−0.242, P=0.033). Calciuria is associated with bone mass decrease in hypertensive women, and there is no relation between bone mass and blood pressure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McCarron DA et al. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinarycalcium leak. Hypertension 1980; 2: 162–168.

    Article  CAS  Google Scholar 

  2. Young EV, Morris CD, McCarron DA . Urinary calcium excretion in essential hypertension. J Lab Clin Med 1992; 120: 624–632.

    CAS  PubMed  Google Scholar 

  3. Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A . Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J 1988; 296: 814–816.

    Article  CAS  Google Scholar 

  4. Brickman AS et al. Calcitropic hormones, platelet calcium and blood pressure in essential hypertension. Hypertension 1990; 16: 512–522.

    Article  Google Scholar 

  5. McCarron DA . Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med 1982; 307: 226–228.

    Article  CAS  Google Scholar 

  6. Gadallah M et al. Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function. Am J Hypertens 1991; 4: 404–409.

    Article  CAS  Google Scholar 

  7. Wang TM, Hsu JF, Jee WSS, Matthews JL . Evidence for reduced cancellous bone mass in the spontaneously hypertensive rats. Bone Mineral 1993; 20: 251–264.

    Article  CAS  Google Scholar 

  8. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA . High blood pressure and bone mineral loss in elderly white women: a prospective study. Lancet 1999; 354: 971–975.

    Article  CAS  Google Scholar 

  9. Delmas PD, Eastell R, Garnero P et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int 2000; 6: S2–S17.

    Article  Google Scholar 

  10. Diaz Curiel M et al. Prevalencia de osteoporosis por densitometría en la población femenina española. Med Clin Barcelona 2001; 116: 86–88.

    Article  CAS  Google Scholar 

  11. Tsuda K, Nistui I, Masuyama Y . Bone: mineral density in women with essential hypertension. Am J Hypertens 2001; 14: 704–707.

    Article  CAS  Google Scholar 

  12. Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB . Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 2000; 13: 169–177.

    CAS  PubMed  Google Scholar 

  13. Cruz DN et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37: 1458–1464.

    Article  CAS  Google Scholar 

  14. Cruz DM . The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density? Nephrol Dial Transplant 2001; 16: 691–694.

    Article  CAS  Google Scholar 

  15. Borry EL et al. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effects of thiazide diuretics. Am J Physiol 1997; 272: C109–C116.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J L Pérez-Castrillón.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pérez-Castrillón, J., Justo, I., Silva, J. et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens 17, 107–110 (2003). https://doi.org/10.1038/sj.jhh.1001520

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001520

Keywords

This article is cited by

Search

Quick links